Heron Therapeutics | HRTX - Ativo Circulante

Preço das Ações
0.80
Mudança Diária
0.02 2.70%
Mensal
-26.61%
Anual
-67.08%
Q1 Previsão
0.76




Ativo Circulante Alterar Data
ALKERMES USD 1.93B 187.5M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amarin USD 649.88M 21.55M 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Anika Therapeutics USD 103.36M 1.77M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Surmodics USD 81.3M 948K 2024-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Veracyte USD 488.38M 39.15M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12